| Literature DB >> 28931750 |
Anne-Lise Lecoq1,2,3, Constantine A Stratakis4, Say Viengchareun1,2, Ronan Chaligné5,6, Lucie Tosca2,7,8, Vianney Deméocq1, Mirella Hage1, Annabel Berthon4, Fabio R Faucz4, Patrick Hanna9, Hadrien-Gaël Boyer10, Nicolas Servant11,12, Sylvie Salenave3, Gérard Tachdjian2,7,8, Clovis Adam13, Vanessa Benhamo5,6, Eric Clauser14, Anne Guiochon-Mantel1,2,15, Jacques Young1,2,3, Marc Lombès1,2,3, Isabelle Bourdeau16, Dominique Maiter17, Antoine Tabarin18, Jérôme Bertherat19, Hervé Lefebvre10, Wouter de Herder20, Estelle Louiset10, André Lacroix16, Philippe Chanson1,2,3, Jérôme Bouligand1,2,15, Peter Kamenický1,2,3.
Abstract
GIP-dependent Cushing's syndrome is caused by ectopic expression of glucose-dependent insulinotropic polypeptide receptor (GIPR) in cortisol-producing adrenal adenomas or in bilateral macronodular adrenal hyperplasias. Molecular mechanisms leading to ectopic GIPR expression in adrenal tissue are not known. Here we performed molecular analyses on adrenocortical adenomas and bilateral macronodular adrenal hyperplasias obtained from 14 patients with GIP-dependent adrenal Cushing's syndrome and one patient with GIP-dependent aldosteronism. GIPR expression in all adenoma and hyperplasia samples occurred through transcriptional activation of a single allele of the GIPR gene. While no abnormality was detected in proximal GIPR promoter methylation, we identified somatic duplications in chromosome region 19q13.32 containing the GIPR locus in the adrenocortical lesions derived from 3 patients. In 2 adenoma samples, the duplicated 19q13.32 region was rearranged with other chromosome regions, whereas a single tissue sample with hyperplasia had a 19q duplication only. We demonstrated that juxtaposition with cis-acting regulatory sequences such as glucocorticoid response elements in the newly identified genomic environment drives abnormal expression of the translocated GIPR allele in adenoma cells. Altogether, our results provide insight into the molecular pathogenesis of GIP-dependent Cushing's syndrome, occurring through monoallelic transcriptional activation of GIPR driven in some adrenal lesions by structural variations.Entities:
Keywords: Endocrinology; Molecular pathology
Mesh:
Substances:
Year: 2017 PMID: 28931750 PMCID: PMC5621881 DOI: 10.1172/jci.insight.92184
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708